Status:
COMPLETED
The Mannitol-Asthma-Ciclesonide-Study
Lead Sponsor:
Cantonal Hosptal, Baselland
Conditions:
Asthma, Bronchial
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
Response of a 4 weeks treatment with daily once 320 µg ciclesonide on airway hyperresponsiveness assessed with mannitol. Hypothesis: Treatment with inhaled ciclesonide reduces airway hyper-responsive...
Eligibility Criteria
Inclusion
- Referred to the pulmonology department of the university hospital Basel because of suspected asthma defined as respiratory symptoms like wheezing or cough or chest tightness.
- Asthma symptoms partly controlled according to GINA (Global Initiative for Asthma, October 2006) 1 week prior to randomization
- FEV1 ≥ 70% predicted
Exclusion
- Smoker and ex-smoker with \>10 pack years
- COPD (chronic obstructive pulmonary disease)
- Upper respiratory tract infection within the past 4 weeks.
- ICS or oral steroids during the previous month before inclusion
- beta-blockers within the past 4 weeks
- Current treatment with medication as defined in section concomitant medication (ICS other than study medication, ß-blockers)
- Pregnancy
- Known malignancy
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT03839433
Start Date
June 1 2007
End Date
August 1 2008
Last Update
July 25 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.